Advanced search
Publication Cover
Australian Journal of Forensic Sciences Volume 49, 2017 - Issue 6
Submit an article Journal homepage
125
Views
3
CrossRef citations to date
0
Altmetric
Papers

An unusual fatal case of overdose of Vinblastine and review of literature

Elvira Ventura SpagnoloDepartment of Biotechnology and Legal Medicine, University of Palermo, Palermo, ItalyCorrespondence[email protected]
,
Cristina MondelloDepartment of Biomedical Science and of Morphological and Functional Images, University of Messina, Gazzi Messina, Italy
,
Francesca IndoratoDepartment of Medical Science, Surgery and Advanced Technologies, “G. F. Ingrassia” – Section of Legal Medicine, University of Catania
,
Luigi CardiaDepartment of Neurosciences, University of Messina, Gazzi, Italy
,
Cataldo RaffinoLegal Medicine Centre of INAIL, Enna, Italy
,
Giulio CardiaDepartment of Biomedical Science and of Morphological and Functional Images, University of Messina, Gazzi Messina, Italy
&
Giovanni BartoloniDepartment GB ‘Ingrassia’, University of Catania, Catania, Italy
 show all
Pages 704-710 | Received 12 Feb 2016, Accepted 23 May 2016, Published online: 21 Jun 2016

References

  • Spiller M, Marson P, Perilongo G, Farina M, Carli M, Bisogno G. A case of vinblastine overdose managed with plasma exchange. Pediatric Blood & Cancer. 2005;45:344–346.10.1002/(ISSN)1545-5017
  • Winter SC, Arbus GS. Syndrome of inappropriate secretion of antidiuretic hormon secondary to vinblastine overdose. Can. Med. Assoc. J. 1977;117(10):1134.
  • Conter V, Rabbone ML, Jankovic M, Fraschini D, Corbetta A, Pacheco C, D’Angelo P, Masera G. Overdose of vinblastine in a child with langerhans' cell histiocytosis: toxicity and salvage therapy. J Pediatr Hematol Oncol. 1991;8(2):165–169.10.3109/08880019109033444
  • Aversa SM, Zanon S, Marino D, Canova F, Chiarion-Sileni V, Jirillo A. Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy. Immunopharmacol Immunotoxicol. 2012;34(5):879–880.10.3109/08923973.2012.663759
  • Kłys M, Konopka T, Scisłowski M, Kowalski P. Fatality involving vinblastine overdose as a result of a complex medical error. Cancer Chemother. Pharmacol. 2007;59(1):89–95.
  • Gilbar P. Palmar-plantar erythrodysestesia. J Oncol Pharm Pract. 2003;9:137–150.10.1191/1078155203jp114oa
  • Childress J, Lokich J. Cutaneous hand and foot toxicity associated with cancer chemotherapy. J Clin Oncol. 2003;26:435–436.10.1097/01.coc.0000026486.56886.18
  • Muller T. Typical medication errors in oncology: analysis and prevention strategies. Onkologie. 2003;26:539–544.
  • Lustig A. Medication error prevention by pharmacists – an Israeli solution. Pharm. World Sci. 2000;22:21–25.10.1023/A:1008774206261
  • Ford CD, Killebrew J, Fugitt P, Jacobsen J, Prystas EM. Study of medication errors on a community hospital oncology ward. J. Oncol. Pract. 2006;2:149–154.10.1200/JOP.2.4.149
  • Schwappach DLB, Wernli M. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur. J. Cancer Care. 2010;19:285–292.10.1111/ecc.2010.19.issue-3
  • Tsang RY, Al-Fayea T, Au HJ. Cisplatin overdose: toxicities and management. Drug Saf. 2009;32(12):1109–1122.10.2165/11316640-000000000-00000
  • Soloni P, Compostella A, Carli M, Bisogno G. A case of oxaliplatin overdose. Pediatr. Blood Cancer. 2009;52(7):902–903.10.1002/pbc.v52:7
  • Dehours E, Riu B, Valle B, Chatelut E, Recher C, Fourcade O, Huguet F. Overdose with 16,000 mg of imatinib mesylate. Leuk. Res. 2010;34(10):e286–e287.10.1016/j.leukres.2010.05.005
  • Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, Papadatos J, Stefanidis CG, Vlachos P, Scardoutsou A, Kostakis A. Vincristine overdose: experience with 3 patients. Pediatr. Hematol. Oncol. 1991;8(2):171–178.10.3109/08880019109033445
  • Moisa A, Fritz P, Benz D, Wehner HD. Iatrogenically-related, fatal methotrexate intoxication: a series of four cases. Forensic Sci. Int. 2006;156(2-3):154–157.10.1016/j.forsciint.2004.12.031
  • Jurek T, Rorat M, Dys P, Swiatek B. Fatal cisplatin overdose in the treatment of mediastinal lymphoma with the ESHAP regimen - analysis of the causes of the adverse drug event. Onkologie. 2013;36(1-2):49–52.10.1159/000346677
  • Charlier C, Kintz P, Dubois N, Plomteux G. Fatal Overdosage with Cisplatin. J. Anal. Toxicol. 2004;28(2):138–140.10.1093/jat/28.2.138

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.